Relay Therapeutics, Inc. · NASDAQ:RLAY
Casdin Capital, LLC reported a 7.50% stake in Relay Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Casdin Capital, LLC reported a 7.50% stake in Relay Therapeutics, Inc., 13,003,574 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 7.50%
- Shares
- 13,003,574
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| CASDIN CAPITAL, LLC | 7.50% | 13,003,574 |
| CASDIN PARTNERS MASTER FUND, L.P. | 7.30% | 12,585,000 |
| CASDIN PARTNERS GP, LLC | 7.50% | 13,003,574 |
| ELI CASDIN | 7.50% | 13,003,574 |
Source
Related
- Relay Therapeutics, Inc.
- Casdin Capital, LLC
- Relay Therapeutics, Inc. shareholders
- Schedule 13G/A · Casdin Capital, LLC · Feb 17, 2026
- Form 4 · Patel Sanjiv · Oct 8, 2026
- Form 4 · Catinazzo Thomas · Oct 8, 2026
- Form 4 · Bergstrom Donald A · Sep 9, 2026
- Form 4 · Catinazzo Thomas · Sep 9, 2026
- Form 4 · Patel Sanjiv · Sep 9, 2026